If the m/m results prove better efficacy than SOC
Post# of 144695
If they do ask for P3, then the other catalysts you are overlooking include BP partnership and/or selling Leronlimab to other countries.
If the situation weren’t as dire, I could envision the FDA kicking the can. If Leron is safe and even mildly effective I would imagine the FDA will be onboard with shooting it into as many COVID-ravaged bellies as possible.
I guess we’ll find out in the next few days.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)